muscle loss on glp-1 Glucagon-like peptide-1 receptor agonists and mass effects Who says you have to
Description
[DOI] [PubMed] [Google Scholar] 166
Int J Cardiol 2011;153:141-7.ArticlePubMed 672
All trademarks and brand names are property of their respective owners

You deserve to feel your best

These medications work by binding to GLP-1 receptors in the body, which increases insulin production in response to food intake and suppresses glucagon, a hormone that raises blood sugar
